MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
31.97
+1.43 (4.68%)
At close: Dec 5, 2025, 4:00 PM EST
31.35
-0.62 (-1.94%)
After-hours: Dec 5, 2025, 7:49 PM EST
MBX Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -80.5 | -61.92 | -32.56 | -26.14 |
| Depreciation & Amortization | 0.25 | 0.24 | 0.16 | 0.06 |
| Loss (Gain) From Sale of Assets | - | - | 0.07 | - |
| Loss (Gain) From Sale of Investments | -4.45 | -2.93 | -1.04 | -0.03 |
| Stock-Based Compensation | 7.51 | 5.22 | 2.04 | 0.31 |
| Other Operating Activities | 0.13 | 0.11 | 0.1 | 1.39 |
| Change in Accounts Payable | -0.95 | 3.93 | 0.41 | 0.67 |
| Change in Other Net Operating Assets | 0.33 | 0.67 | -1.15 | 0.62 |
| Operating Cash Flow | -77.69 | -54.68 | -31.98 | -23.12 |
| Capital Expenditures | -1.23 | -0.87 | -0.13 | -0.44 |
| Investment in Securities | -19.85 | -159.72 | -30.8 | -10.97 |
| Investing Cash Flow | -21.08 | -160.6 | -30.93 | -11.41 |
| Short-Term Debt Issued | - | - | - | 10 |
| Total Debt Issued | - | - | - | 10 |
| Net Debt Issued (Repaid) | - | - | - | 10 |
| Issuance of Common Stock | 189.6 | 174.95 | 0.74 | 0.03 |
| Other Financing Activities | -0.58 | -4.34 | -0.03 | -0.46 |
| Financing Cash Flow | 189.02 | 234.1 | 69.22 | 46.06 |
| Net Cash Flow | 90.26 | 18.83 | 6.31 | 11.53 |
| Free Cash Flow | -78.91 | -55.56 | -32.11 | -23.56 |
| Free Cash Flow Per Share | -2.35 | -5.22 | -31.52 | -35.33 |
| Levered Free Cash Flow | -50.83 | -33.27 | -20.56 | - |
| Unlevered Free Cash Flow | -50.83 | -33.27 | -20.56 | - |
| Change in Working Capital | -0.62 | 4.6 | -0.74 | 1.29 |
Source: S&P Capital IQ. Standard template.
Financial Sources.